JP2023553014A5 - - Google Patents
Info
- Publication number
- JP2023553014A5 JP2023553014A5 JP2023534100A JP2023534100A JP2023553014A5 JP 2023553014 A5 JP2023553014 A5 JP 2023553014A5 JP 2023534100 A JP2023534100 A JP 2023534100A JP 2023534100 A JP2023534100 A JP 2023534100A JP 2023553014 A5 JP2023553014 A5 JP 2023553014A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063121164P | 2020-12-03 | 2020-12-03 | |
| US63/121,164 | 2020-12-03 | ||
| PCT/US2021/061876 WO2022120217A2 (en) | 2020-12-03 | 2021-12-03 | Homologous adenoviral vaccination |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023553014A JP2023553014A (ja) | 2023-12-20 |
| JPWO2022120217A5 JPWO2022120217A5 (https=) | 2024-12-10 |
| JP2023553014A5 true JP2023553014A5 (https=) | 2024-12-10 |
Family
ID=81854908
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023534100A Pending JP2023553014A (ja) | 2020-12-03 | 2021-12-03 | 同種アデノウイルスワクチン接種の方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240093235A1 (https=) |
| EP (1) | EP4255477A4 (https=) |
| JP (1) | JP2023553014A (https=) |
| KR (1) | KR20230117163A (https=) |
| CN (1) | CN116669760A (https=) |
| AU (1) | AU2021391921A1 (https=) |
| CA (1) | CA3200935A1 (https=) |
| IL (1) | IL303298A (https=) |
| WO (1) | WO2022120217A2 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040136963A1 (en) * | 2001-06-22 | 2004-07-15 | The Trustees Of The University Of Pennsylvania | Simian adenovirus vectors and methods of use |
| CN112368386A (zh) * | 2018-05-23 | 2021-02-12 | 磨石肿瘤生物技术公司 | 共有抗原 |
| BR112021010611A2 (pt) * | 2018-12-14 | 2021-08-24 | Glaxosmithkline Biologicals S.A. | Composições e métodos de vacina de reforço (prime boost) heterólogo |
| WO2021092095A1 (en) * | 2019-11-04 | 2021-05-14 | Gritstone Oncology, Inc. | Neoantigen vaccine therapy |
-
2021
- 2021-12-03 WO PCT/US2021/061876 patent/WO2022120217A2/en not_active Ceased
- 2021-12-03 AU AU2021391921A patent/AU2021391921A1/en active Pending
- 2021-12-03 CN CN202180081878.0A patent/CN116669760A/zh active Pending
- 2021-12-03 JP JP2023534100A patent/JP2023553014A/ja active Pending
- 2021-12-03 KR KR1020237021567A patent/KR20230117163A/ko active Pending
- 2021-12-03 IL IL303298A patent/IL303298A/en unknown
- 2021-12-03 CA CA3200935A patent/CA3200935A1/en active Pending
- 2021-12-03 EP EP21901562.5A patent/EP4255477A4/en active Pending
- 2021-12-03 US US18/272,087 patent/US20240093235A1/en active Pending